High-quality food-grade mEV ingredients begin with a production infrastructure engineered for compliance, not adapted to it. At Creative BioMart Microbe, our Food-Grade Exosome Production Services translate laboratory-scale mEV protocols into contaminant-controlled, food-ingredient-ready manufacturing under conditions that satisfy FDA 21 CFR, EFSA novel food guidance, and Codex Alimentarius frameworks for microbial-derived ingredients.
Every batch produced through this platform undergoes a multi-panel safety screen covering pathogen exclusion (Salmonella, Listeria monocytogenes, E. coli O157:H7, coagulase-positive Staphylococcus aureus), heavy metal quantification (Pb, Cd, As, Hg), allergen residue analysis, and endotoxin measurement. The production environment operates under documented sanitation protocols with validated cleaning verification, segregated raw material handling, and environmental monitoring—not merely an add-on QC check at the end, but an embedded quality system woven into every unit operation. Clients receive production batches supported by batch-specific Certificates of Analysis, safety testing reports, and regulatory documentation packages designed for GRAS self-affirmation dossiers or novel food submissions. Contact us to discuss your food-grade mEV production requirements.

Figure 1. Schematic overview of the food-grade exosome production platform, integrating food-safe strain verification, contaminant-controlled fermentation, multi-panel food-safety testing, endotoxin and allergen control, and batch documentation release into a comprehensive quality framework.
Our production workflow follows a contaminant-controlled, batch-documented pipeline that treats food safety as a process attribute rather than an endpoint test. Each stage—from incoming strain qualification through final batch release—is governed by predefined acceptance criteria, in-process monitoring checkpoints, and traceable documentation. The result is mEV preparations that are analytically characterized, safety-tested, and ready for integration into functional food products, nutraceutical formulations, or medical food development programs.

Food-Safe Strain Sourcing & GRAS/QPS Regulatory Verification
We qualify production strains against food-grade regulatory frameworks through species-level identity confirmation, safety characterization, and regulatory status documentation. Our platform maintains a curated panel of GRAS-notified Bacillus subtilis strains and QPS-listed lactic acid bacteria and bifidobacteria ready for immediate deployment. Client-provided isolates undergo the same rigorous qualification pipeline with full traceability. The output is a regulatory-positioning dossier that maps each strain to applicable food safety frameworks and identifies any data gaps requiring resolution before production scale-up.

Contaminant-Controlled Fermentation & Production
We operate dedicated food-grade production suites with segregated material flow, validated cleaning and sanitization protocols, environmental monitoring programs, and personnel hygiene controls aligned with food manufacturing GMPs. Fermentation is conducted in closed-system bioreactors using food-grade media components with documented supplier qualification. Each production campaign is bracketed by pre- and post-campaign environmental swabbing and equipment rinse-water testing to verify sanitization effectiveness.

Multi-Panel Food-Safety Testing
Each production batch undergoes a comprehensive food-safety testing battery: pathogen screening for Salmonella spp., Listeria monocytogenes, E. coli O157:H7, and coagulase-positive Staphylococcus aureus; heavy metal quantification by ICP-MS for Pb, Cd, As, and Hg; allergen residue analysis covering milk, soy, gluten, and egg; and endotoxin measurement by LAL or recombinant factor C assay. Optional extended panels for mycotoxins and pesticide residues are available for clients pursuing specific market-access requirements.

Endotoxin & Allergen Control
Beyond detection, we implement active control strategies for endotoxin and allergen risk. Endotoxin reduction is achieved through validated purification steps including detergent-free phase separation and affinity depletion, with lot release testing confirming endotoxin levels within food-grade thresholds. Allergen control is managed through dedicated equipment segregation, validated allergen cleaning protocols, and raw material supplier allergen declarations. Clients targeting allergen-free labeling claims receive a comprehensive allergen risk assessment and supporting documentation.

Batch Documentation & Certificate of Analysis
Every production batch is released with a comprehensive documentation package: a batch-specific Certificate of Analysis summarizing all safety test results, physico-chemical characterization data, and acceptance criteria conformance; a production batch record documenting process parameters, in-process controls, and deviations; and a regulatory support dossier compiling strain qualification evidence, safety testing methodology, and compliance statements mapped to target-market food regulations. Documentation is formatted to support GRAS self-affirmation packages and novel food authorization submissions.
| Parameter | Specification |
|---|---|
| Production Suites | Dedicated food-grade segregated suites; no shared equipment with research-grade or pharmaceutical operations |
| Environmental Classification | Controlled access; HEPA-filtered air supply; positive pressure maintenance; monitored temperature and humidity |
| Cleaning Validation | CIP/SIP protocols; pre- and post-campaign environmental swabbing; equipment rinse-water testing |
| Material Flow | Unidirectional segregated flow from raw material receipt through production to batch release |
| Personnel Controls | Hygiene protocols, gowning requirements, and access logging aligned with food manufacturing practices |
| Control Stage | Monitored Parameters | Acceptance Criteria |
|---|---|---|
| Pre-production | Environmental monitoring (air, surfaces, water); equipment qualification status | All within established limits; equipment IQ/OQ/PQ current |
| Inoculum preparation | Optical density, purity check, viability | OD within target range; Gram stain pure; viability >90% |
| Fermentation mid-point | pH, dissolved oxygen, optical density, temperature | All within strain-specific SOP ranges |
| Harvest | Culture purity, endotoxin level, optical density | No contamination; endotoxin within food-grade threshold |
| Post-purification | Particle concentration, size distribution, zeta potential, purity | NTA and DLS within batch release specifications |
| Batch release | Full safety panel, physico-chemical characterization, documentation completeness | All acceptance criteria met; CoA issued |
| Test Category | Analytes / Targets | Acceptance Criterion |
|---|---|---|
| Pathogen Screening | Salmonella spp., Listeria monocytogenes, E. coli O157:H7, coagulase-positive Staphylococcus aureus | Absent per batch |
| Heavy Metals | Pb, Cd, As, Hg | Reported; within food-grade regulatory limits |
| Allergen Residues | Milk, Soy, Gluten, Egg | Reported; < applicable threshold |
| Endotoxin | LAL / recombinant factor C | Reported per batch |
| Mycotoxins (optional) | Aflatoxins B1/B2/G1/G2, Ochratoxin A, Zearalenone, Deoxynivalenol | Reported; within regulatory limits |
| Pesticide Residues (optional) | Multi-residue panel | Reported; within regulatory limits |
| Parameter | Specification |
|---|---|
| Eligible Strains | GRAS Bacillus subtilis, GRAS/QPS-listed lactic acid bacteria, QPS-listed Bifidobacterium and Lactobacillus spp. |
| Production Scale | Flexible batch production with scale-up pathway development |
| Vesicle Yield | 1012 – 1015 particles per batch |
| Particle Size (NTA) | 30 – 300 nm |
| Zeta Potential | −10 to −40 mV (strain-dependent) |
| Production Environment | Food-grade segregated suites; validated cleaning and sanitization |
| Media Components | Food-grade; supplier-qualified; documented traceability |
| Process Monitoring | Temperature, pH, dissolved oxygen, optical density; real-time recording |
| Project Type | Timeline |
|---|---|
| Strain qualification and GRAS/QPS verification (existing strain) | 2–3 weeks |
| Strain qualification (client-provided, new isolate) | 4–6 weeks |
| Fermentation process transfer and adaptation | 3–4 weeks |
| Single production batch (development scale) | 3–4 weeks |
| Single production batch (pilot scale) | 5–6 weeks |
| Multi-batch production campaign (3 batches) | 8–12 weeks |
| Expedited timeline | +50% fee, 40% time reduction |
Timeline may vary based on strain complexity, production scale, and safety testing scope.
| Required Information | Optional Information | Not Accepted |
|---|---|---|
|
|
|
Recommended Starting Material by Service:
| Service | Minimum | Recommended |
|---|---|---|
| Strain qualification (existing strain) | Glycerol stock or lyophilized culture | 1 mL glycerol stock (15% v/v glycerol) |
| Strain qualification (new isolate) | Active culture on agar slant | 1 mL glycerol stock + agar slant |
| Fermentation process transfer | 1 qualified strain + protocol | 3 qualified strains for parallel comparison |
| Single production batch (small scale) | 500 mL – 1 L culture volume | 2–5 L culture volume |
| Multi-batch production campaign | 1 qualified strain | 2–3 strains with comparative analysis |
Storage & Shipping: Ship production strains as glycerol stocks on dry ice with cold-chain documentation. Provide strain origin, isolation history, prior characterization data, and any existing safety assessment reports. For client-provided strains, include a completed strain information form detailing species, source, and intended food application. Non-food-safe or pathogenic strains cannot be accepted for food-grade production under any circumstances.

Pilot-Scale Production for Feasibility Studies
Small-batch production campaigns to validate strain productivity, establish baseline safety profiles, and generate preliminary CoA data for investor or regulatory pre-submission meetings.

Multi-Batch Campaigns for Stability Programs
Structured multi-batch production with inter-batch consistency monitoring to support shelf-life studies, process robustness validation, and regulatory dossier requirements for commercial authorization.

Strain Comparison & Selection Campaigns
Head-to-head production runs across multiple GRAS or QPS strains with standardized analytics to identify the optimal vesicle-producing candidate for a target application or regulatory pathway.

Technology Transfer to CMO Partners
Comprehensive tech-transfer packages including qualified production protocols, validated analytical methods, and acceptance criteria for seamless scale-up to commercial contract manufacturing organizations.
A: Food-grade production operates under documented food manufacturing practices with segregated suites, validated cleaning protocols, environmental monitoring, and supplier-qualified food-grade raw materials. Every batch undergoes the complete multi-panel food-safety testing battery—pathogens, heavy metals, allergens, and endotoxin. Research-grade preparation is conducted in standard laboratory conditions without these food-safety controls or release testing. The two are operationally and infrastructurally distinct, and research-grade material cannot be retrospectively “upgraded” to food-grade status.
A: Eligible strains include GRAS-notified Bacillus subtilis, QPS-listed lactic acid bacteria (Lactobacillus, Lactiplantibacillus, Limosilactobacillus, Levilactobacillus, Lactococcus, Streptococcus), QPS-listed Bifidobacterium spp., and other species with documented safe-use history in food. Strains harboring transferable antibiotic resistance genes, known virulence factors, or toxin production capability are excluded regardless of taxonomic classification. Custom strain qualification for client-provided isolates is available.
A: Every batch is tested for: (1) pathogen exclusion—Salmonella spp., Listeria monocytogenes, E. coli O157:H7, coagulase-positive Staphylococcus aureus; (2) heavy metals—Pb, Cd, As, Hg by ICP-MS; (3) allergen residues—milk, soy, gluten, egg by immunoassay; (4) endotoxin—by LAL or recombinant factor C assay. Extended optional panels for mycotoxins and pesticide residues are available. All results appear on the batch Certificate of Analysis.
A: Yes, subject to our strain qualification pipeline. Client-provided strains undergo species identity confirmation, safety profiling (antibiotic resistance, hemolytic activity, virulence factor screening, biogenic amine production), and regulatory status assessment. Strains must meet all food-grade safety criteria before production can commence. The qualification process typically takes 4–6 weeks. All client strains are handled under confidentiality agreements with secure strain banking.
A: Between campaigns, equipment undergoes CIP/SIP cleaning cycles followed by rinse-water testing for residual media components and endotoxin. Surface swabbing with ATP bioluminescence monitoring verifies sanitization effectiveness. Environmental air sampling confirms suite cleanliness before the next campaign begins. All cleaning verification results are documented in the production batch record. Dedicated allergen-free campaigns require additional validated allergen-specific cleaning protocols and residue testing.
A: OOS events trigger a structured investigation protocol: immediate batch hold pending root-cause analysis, review of in-process control data and environmental monitoring records, equipment and analyst qualification verification, and identification of corrective and preventive actions (CAPA). Batches failing safety-critical acceptance criteria (pathogen presence, excessive heavy metals) are rejected and destroyed. Batches with non-critical deviations may be reprocessed or released with documented justification depending on client agreement and regulatory requirements.
A: Cross-contamination prevention is managed through: dedicated, segregated food-grade production suites; validated cleaning and sanitization protocols with documented effectiveness; pre- and post-campaign environmental monitoring (surface swabbing, air sampling, equipment rinse-water testing); single-strain campaigns with full suite sanitization between strains; and raw material segregation with dedicated storage. Cleaning verification results are included in the production batch record.
Enter your email here to subscribe